Featured Research

from universities, journals, and other organizations

Parkinson's Drugs Tradeoff: Better Muscle Control, Worse Side Effects, Review Shows

Date:
April 20, 2008
Source:
Center for the Advancement of Health
Summary:
Compared to older drugs for Parkinson disease, a newer class of medications called dopamine agonists might be better at preventing some of the disabling muscle control problems associated with the disease and its treatment, a new review concludes. However, patients who take the new drugs suffer from an increase in numerous side effects, and are more likely to drop out of treatment.

Compared to older drugs for Parkinson disease, a newer class of medications called dopamine agonists might be better at preventing some of the disabling muscle control problems associated with the disease and its treatment, a new review of recent studies concludes.

However, patients who take dopamine agonists suffer from an increase in numerous side effects -- from sleepiness to nausea to hallucinations in some cases -- and are more likely to drop out of treatment than those who take the older treatment levodopa or no drugs at all.

"Patients taking dopamine agonists were more than twice as likely to quit treatment, suggesting that the side effects were severe enough to have a meaningful impact on patients' quality of life, outweighing the muscle control problems," said Rebecca Stowe of the University of Birmingham, the review's lead author.

The review of studies appears in a recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews like this one draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

Parkinson's disease is a degenerative disease of the nervous system that can impair a person's movements and speech. Dopamine agonists, drugs that stimulate the production of the important neurotransmitter dopamine in the brain, are increasingly used as first-line therapies for the disease.

Levodopa, an older drug that can be metabolized in the brain to produce dopamine, is also used widely in Parkinson's treatment. However, patients who use levodopa over long periods can develop painful, distorting, involuntary muscle spasms and repetitive movements.

Stowe and colleagues reviewed 29 studies that included 5,247 patients who were in the early stages of Parkinson's disease and did not show any significant signs of muscle and movement problems. Some of the studies compared dopamine agonists only with levodopa, while some used a combination of dopamine agonists and levodopa.

There was no significant difference in the death rates between patients using dopamine agonists and those who did not take the drugs, the researchers found.

"Importantly, the review highlights that the balance of risks and benefits of dopamine agonists remains unclear," said Stowe, who called for further studies on patients' overall quality of life and the economic costs of the treatments.

Researchers are tracking another troubling effect of dopamine agonists -- their potential link to impulsive behaviors such as uncontrolled gambling and hypersexuality. Dr. Joseph Jankovic, a Parkinson's disease and motor disorders expert at the Baylor College of Medicine, said dopamine agonists "play an important role in triggering these nonmotor symptoms" that appear in some patients with Parkinson's disease, particularly men and those who develop the disease as younger adults.

Reference: Stowe RL, et al. Dopamine agonist therapy in early Parkinson disease. The Cochrane Database of Systematic Reviews 2008, Issue 2.


Story Source:

The above story is based on materials provided by Center for the Advancement of Health. Note: Materials may be edited for content and length.


Cite This Page:

Center for the Advancement of Health. "Parkinson's Drugs Tradeoff: Better Muscle Control, Worse Side Effects, Review Shows." ScienceDaily. ScienceDaily, 20 April 2008. <www.sciencedaily.com/releases/2008/04/080415194241.htm>.
Center for the Advancement of Health. (2008, April 20). Parkinson's Drugs Tradeoff: Better Muscle Control, Worse Side Effects, Review Shows. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2008/04/080415194241.htm
Center for the Advancement of Health. "Parkinson's Drugs Tradeoff: Better Muscle Control, Worse Side Effects, Review Shows." ScienceDaily. www.sciencedaily.com/releases/2008/04/080415194241.htm (accessed July 31, 2014).

Share This




More Mind & Brain News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Dieting At A Young Age Might Lead To Harmful Health Habits

Dieting At A Young Age Might Lead To Harmful Health Habits

Newsy (July 30, 2014) Researchers say women who diet at a young age are at greater risk of developing harmful health habits, including eating disorders and alcohol abuse. Video provided by Newsy
Powered by NewsLook.com
It's Not Just Facebook: OKCupid Experiments With Users Too

It's Not Just Facebook: OKCupid Experiments With Users Too

Newsy (July 29, 2014) If you've been looking for love online, there's a chance somebody has been looking at how you're looking. Video provided by Newsy
Powered by NewsLook.com
How Your Face Can Leave A Good Or Bad First Impression

How Your Face Can Leave A Good Or Bad First Impression

Newsy (July 29, 2014) Researchers have found certain facial features can make us seem more attractive or trustworthy. Video provided by Newsy
Powered by NewsLook.com
Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins